Katherine Beardman serves as the Executive Director and Head of People & Organization for Global Commercial & Medical at Novartis Gene Therapies, where she plays a pivotal role in shaping the company's human resources strategy across Europe, the Middle East, Africa, Asia, Australia, Japan, and...
Katherine Beardman serves as the Executive Director and Head of People & Organization for Global Commercial & Medical at Novartis Gene Therapies, where she plays a pivotal role in shaping the company's human resources strategy across Europe, the Middle East, Africa, Asia, Australia, Japan, and China. With over 19 years of global HR leadership experience, Katherine has established herself as a key driver of organizational design and talent management within the biopharmaceutical sector. Her expertise lies in aligning HR initiatives with strategic business objectives, particularly in the fast-evolving landscape of gene therapies for rare and life-threatening diseases.
In her current role, Katherine leads several high-impact projects aimed at enhancing employee engagement and optimizing Total Rewards processes. She is instrumental in advancing recruitment strategies that attract top talent while ensuring a seamless integration of new hires into the organizational culture. Her focus on change management and retention strategies has been critical in fostering a resilient workforce capable of adapting to the dynamic demands of the industry. Katherine's adeptness in benefits management and employee relations further strengthens her ability to create a supportive and inclusive workplace environment.
Katherine’s commitment to building a fit-for-purpose organization is evident in her strategic oversight of resourcing and organizational phasing, which are essential for sustaining Novartis Gene Therapies' growth trajectory. By leveraging her skills in applicant tracking systems and recruitment advertising, she ensures that the company not only meets its current staffing needs but is also well-prepared for future challenges in the gene therapy space. Through her leadership, Katherine Beardman continues to drive Novartis Gene Therapies toward its mission of transforming patient lives through innovative therapies.
